Chronic Myeloproliferative Disorders Unknown Status Phase 2 Trials for Melphalan (DB01042)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00691015Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantSupportive Care